Hamptons Homebuildi...
Health Care: Drugs
Novavax Inc. (NVAX: NASDAQ)
$2.02 -0.02 | -0.98%
05/24/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -28.51M | -19.36M | -35.71M | -38.37M |
| Operating Gains/Losses | -907.00K | 0.00 | 35.00K | 21.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 5.57M | -3.75M | 204.00K | 32.00K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 2.01M | -2.69M | 1.91M | 2.55M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | -728.00K | 2.50M | -150.00K | 150.00K |
| Other Non-Cash Items | 2.65M | -408.00K | -452.00K | 1.77M |
| Net Cash From Continuing Operations | -18.23M | -23.63M | -32.85M | -32.83M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -18.23M | -23.63M | -32.85M | -32.83M |
| Sale of Property, Plant & Equipment | 324.00K | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 21.24M | 19.00M | 3.10M |
| Purchases of Property, Plant & Equipment | -4.34M | -610.00K | -1.56M | -745.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | -2.08M | -38.72M | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -32.26M | 18.54M | -21.27M | 2.36M |
| Issuance of Debt | 650.00K | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 54.06M | 11.16M | 23.52M | 57.34M |
| Repayment of Long-Term Debt | -164.00K | -80.00K | -86.00K | -15.04M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -756.00K | 50.00K | 0.00 | 0.00 |
| Net Cash From Financing Activities | 53.79M | 11.13M | 23.43M | 42.29M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 3.30M | 6.04M | -30.70M | 11.82M |
Portfolios with NVAX
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- ContributorBreakout Stocks Of The Week...
- UserCy Winther
- UserNale's Holdings
- Contributor10 Pharma Stocks Under $3
- Contributor10 Stocks Under $3 With Upside
- Contributor10 Stocks Under $4 With Upside
- Usergdean1
- Userhisatomi
- UserBruce7677
Latest NVAX Headlines from TheStreet
- Novavax H7N9 VLP Influenza Vaccine Enters Animal Testing 05.10.13 | 08:05 am
- Novavax Reports First-Quarter 2013 Financial Results 05.07.13 | 08:05 am
- Novavax To Report First-Quarter 2013 Financial Results On May 7, 2013 04.26.13 | 08:04 am
- Novavax To Present At 12th Annual Needham Healthcare Conference 04.25.13 | 08:04 am
- Novavax To Review Recent Findings From Vaccine Programs At World Vaccine Congress And Expo In Washington, DC 04.15.13 | 05:04 pm
- Novavax Appoints Amy B. Fix Vice President Of Regulatory Affairs 04.10.13 | 08:04 am
- Novavax Reports Positive Top-Line Results From Phase II Clinical Trial Of RSV Vaccine Candidate In Women Of Childbearing Age 04.02.13 | 04:04 pm
- Novavax Reports Progress On RSV Vaccine At The XV International Symposium On Respiratory Viral Infections 03.18.13 | 08:03 am
- 5 Stocks With Big Insider Buying 03.13.13 | 12:03 pm
- Novavax To Present At The 25th Annual ROTH Conference 03.13.13 | 12:03 pm
Press Releases for NVAX
- U.S. Life Science Companies Raise $53 Million Through Activity Of 19 At-the-Market (ATM) Offerings In First Quarter Of 2011, Data From Brinson Patrick Securities Show - PR Newswire 06.23.11 | 07:06 am
- MLV Announces Formation Of Advisory Board And Appointment Of Dr. Rahul Singhvi As Its Founding Director - PR Newswire 06.03.11 | 10:06 am
- NOVAVAX To Present At The NOBLE FINANCIAL 7th Annual Equity Conference - PR Newswire 05.13.11 | 11:05 am
- Novavax Named Biotechnology Firm Of The Year By Tech Council Of Maryland - PR Newswire 05.11.11 | 09:05 am
- Novavax To Report First Quarter 2011 Financial Results On May 9, 2011 - PR Newswire 05.03.11 | 10:05 am
- Novavax Announces Senior Management Appointments - PR Newswire 04.26.11 | 08:04 am
- Novavax Announces Change In Leadership - PR Newswire 04.19.11 | 04:04 pm
- Novavax's VLP Influenza Vaccine Named One Of Top 100 Drugs In Development Today - PR Newswire 04.05.11 | 08:04 am
- NOVAVAX Announces Release Date Of 2010 Year-End Financial Results And Investor Conference Call - PR Newswire 03.23.11 | 02:03 pm
- NOVAVAX To Present At BIT Life Science's 3rd World Congress Of Vaccine - PR Newswire 03.22.11 | 08:03 am
Partner Headlines for NVAX
- Will Influenza A H7N9 Generate Opportunities For Pharma? - Seeking Alpha 05.21.13 | 09:05 am
- Novavax Earnings: Everything You Must Know Now - Wall St. Cheat Sheet 05.07.13 | 10:05 am
- Novavax Initiates Phase 2 Trial of RSV Vaccine; Sees Reporting Top-Line Results in Q1 2013 - Benzinga 10.08.12 | 01:10 pm
- Johnson & Johnson Gets CERTIFIED and 4 Stocks Enjoying 52-Week Highs - Wall St. Cheat Sheet 07.19.12 | 10:07 am
- NOVAVAX Launches Phase II Clinical Trial of Seasonal Influenza Vaccine - Benzinga 03.01.12 | 04:03 pm
- Oink Oink: Profit From The Return Of Swine Flu - Benzinga 01.12.12 | 01:01 pm
- Gambling With Speculative Healthcare Stocks - Seeking Alpha 09.06.11 | 09:09 am
- Novavax Gets a Federal Grant for Developing Its Novel Flu Vaccine - AOL 03.01.11 | 08:03 pm
- UPDATE 1-FDA clears Novavax trial for anti-viral vaccine - Reuters 12.16.10 | 08:12 am
- Novavax 2Q Earnings Down on High R&D Costs - Fox Business 08.06.10 | 01:08 pm
